Federal Circuit Slams Purdue With Inequitable Conduct Finding In OxyContent Patent Suit
In a major setback for Purdue Pharma, Endo Pharmaceutical Holdings Inc. has won an appeals court ruling allowing it to sell a generic version of the painkiller OxyContin....To view the full article, register now.
Already a subscriber? Click here to view full article